Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 7.45
+0.30 (4.20%)
At close: Jan 8, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 125.44 million as of January 9, 2026. Its market cap has increased by 96.88% in one year.
Market Cap
125.44M
Enterprise Value
102.26M
Revenue
17.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.45
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 125.44M, an increase of 8.52%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 125.44M | - |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | 115.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 1.04T |
| Atlas Copco AB | 835.72B |
| AB Volvo | 623.70B |
| EQT AB | 422.38B |
| ASSA ABLOY AB | 405.10B |
| Sandvik AB | 395.63B |
| Skandinaviska Enskilda Banken AB | 391.06B |
| Swedbank AB | 368.30B |